LMR Partners’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

LMR Partners’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,768	Closed	-$296K	–	1471
2024 Q4	$296K	Hold	10,768	–	–	﹤0.01%	909
2024 Q3	$310K	Hold	10,768	–	–	﹤0.01%	910
2024 Q2	$267K	Hold	10,768	–	–	﹤0.01%	828
2024 Q1	$347K	Hold	10,768	–	–	﹤0.01%	804
2023 Q4	$438K	Hold	10,768	–	–	0.01%	663
2023 Q3	$372K	Hold	10,768	–	–	﹤0.01%	589
2023 Q2	$438K	Hold	10,768	–	–	﹤0.01%	504
2023 Q1	$416K	Buy	+10,768	New	+$443K	0.01%	745
2022 Q3	–	Sell	-8,125	Closed	-$453K	–	1246
2022 Q2	$453K	Sell	8,125 -41,623	-84%	-$2.47M	0.01%	948
2022 Q1	$3.08M	Sell	49,748 -127,132	-72%	-$7.78M	0.04%	430
2021 Q4	$9.75M	Buy	176,880 +76,880	+77%	+$4.01M	0.1%	168
2021 Q3	$5.26M	Buy	+100,000	New	+$5.94M	0.06%	246

Other funds holding LKFT

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LMR Partners's LKFT Position: Q1 2025 in Review

LMR Partners sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2025, closing a stake of 10,768 shares — an estimated $296K sold.

LMR Partners first reported a position in LKFT in Q3 2021 and held it in 12 quarters. The position peaked at $9.75M in Q4 2021. 83 funds tracked by Wall St. Rank hold LKFT as of Q1 2025.

LMR Partners reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2025 after selling out during the quarter.
LMR Partners sold 10,768 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2025, an estimated $296K.
LMR Partners first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2021 and held it in 12 quarters.
LMR Partners's Lakefront Biotherapeutics American Depositary Shares position peaked at $9.75M in Q4 2021.
83 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2025.

Based on LMR Partners's 13F filing for Q1 2025, filed 15 May 2025.